BioCentury | Jan 23, 2021
Product Development

Why COVID master protocols haven’t been productive in the U.S., and how to fix it

If the U.S. hopes to generate substantial, meaningful data on therapies for COVID-19 and future pandemics, it will need to overhaul the clinical trial ecosystem to prioritize master protocols.  At...
BioCentury | May 9, 2020
Deals

jCyte-Santen deal positions CIRM-funded stem cell therapy for pivotal studies, global access

...retinopathy, Bresge said. jCell was developed by co-founders Henry Klassen and Jing Yang at the University of California Irvine...
BioCentury | Feb 26, 2020
Emerging Company Profile

WindMIL: T cell source is key

...refractory to or have relapsed on an anti-PD-1 therapy. The company has partnered with the University of California Irvine...
...Brian Halak and Ivan Borrello University collaborators: University of Pennsylvania, Johns Hopkins, University of Michigan, University of California Irvine...
BioCentury | Dec 13, 2019
Finance

Aspen’s debut reveals first cell therapy investment by Domain

...in August. He was formerly the vice chancellor for health affairs and CEO of the University of California Irvine...
BioCentury | Sep 13, 2019
Tools & Techniques

Getting higher-quality hits out of DNA-encoded libraries

...in isolation, according to Brian Paegel, a professor in the department of pharmaceutical sciences at University of California Irvine...
...Inc., San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. University of California Irvine...
...serine-threonine kinase 1 Allison Johnson, Senior Writer Amgen Inc. GlaxoSmithKline plc HotSpot Therapeutics Inc. Nurix Therapeutics Inc. Roche Pfizer Inc. The Scripps Research Institute University of California Irvine X-Chem...
BioCentury | Jul 18, 2019
Finance

As funding dwindles, CIRM believes goals within reach

...plc (NASDAQ:ORTX); and a retinitis pigmentosa program from the laboratory of Henry Klassen at the University of California Irvine...
...Therapeutics plc (NASDAQ:ORTX), London, U.K. Stanford University, Stanford, Calif. University of California Davis, Davis, Calif. University of California Irvine...
BioCentury | Jan 11, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...ERC-USA and the University of California Irvine announced that a patient with recurrent glioblastoma multiforme is receiving therapeutic vaccine...
...glioblastoma multiforme Endpoint: NA Status: Right to try treatment started Milestone: NA Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University of California Irvine Brain...
BioCentury | Jan 9, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...ERC-USA and the University of California Irvine announced that a patient with recurrent glioblastoma multiforme is receiving therapeutic vaccine...
...those cells. ERC-USA is a subsidiary of ERC-Belgium S.A. (Les Isnes, Belgium). Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University of California Irvine Brain...
BioCentury | Oct 12, 2018
Emerging Company Profile

Spinogenix’s Spine Craft

...Clinical status: Preclinical Founded: 2016 by Stella Sarraf University collaborators: University of California San Diego, University of California Irvine...
BioCentury | Oct 11, 2018
Translation in Brief

Public funding highlights: 3Q18

...for progressing to chronic pain Grants Sept. 6 NIH Bruce Tromberg, a professor at the University of California Irvine...
Items per page:
1 - 10 of 140
BioCentury | Jan 23, 2021
Product Development

Why COVID master protocols haven’t been productive in the U.S., and how to fix it

If the U.S. hopes to generate substantial, meaningful data on therapies for COVID-19 and future pandemics, it will need to overhaul the clinical trial ecosystem to prioritize master protocols.  At...
BioCentury | May 9, 2020
Deals

jCyte-Santen deal positions CIRM-funded stem cell therapy for pivotal studies, global access

...retinopathy, Bresge said. jCell was developed by co-founders Henry Klassen and Jing Yang at the University of California Irvine...
BioCentury | Feb 26, 2020
Emerging Company Profile

WindMIL: T cell source is key

...refractory to or have relapsed on an anti-PD-1 therapy. The company has partnered with the University of California Irvine...
...Brian Halak and Ivan Borrello University collaborators: University of Pennsylvania, Johns Hopkins, University of Michigan, University of California Irvine...
BioCentury | Dec 13, 2019
Finance

Aspen’s debut reveals first cell therapy investment by Domain

...in August. He was formerly the vice chancellor for health affairs and CEO of the University of California Irvine...
BioCentury | Sep 13, 2019
Tools & Techniques

Getting higher-quality hits out of DNA-encoded libraries

...in isolation, according to Brian Paegel, a professor in the department of pharmaceutical sciences at University of California Irvine...
...Inc., San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. University of California Irvine...
...serine-threonine kinase 1 Allison Johnson, Senior Writer Amgen Inc. GlaxoSmithKline plc HotSpot Therapeutics Inc. Nurix Therapeutics Inc. Roche Pfizer Inc. The Scripps Research Institute University of California Irvine X-Chem...
BioCentury | Jul 18, 2019
Finance

As funding dwindles, CIRM believes goals within reach

...plc (NASDAQ:ORTX); and a retinitis pigmentosa program from the laboratory of Henry Klassen at the University of California Irvine...
...Therapeutics plc (NASDAQ:ORTX), London, U.K. Stanford University, Stanford, Calif. University of California Davis, Davis, Calif. University of California Irvine...
BioCentury | Jan 11, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...ERC-USA and the University of California Irvine announced that a patient with recurrent glioblastoma multiforme is receiving therapeutic vaccine...
...glioblastoma multiforme Endpoint: NA Status: Right to try treatment started Milestone: NA Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University of California Irvine Brain...
BioCentury | Jan 9, 2019
Clinical News

Patient receives glioblastoma vaccine under right to try

...ERC-USA and the University of California Irvine announced that a patient with recurrent glioblastoma multiforme is receiving therapeutic vaccine...
...those cells. ERC-USA is a subsidiary of ERC-Belgium S.A. (Les Isnes, Belgium). Chris Lieu Gliovac (ERC1671) ERC Belgium S.A. University of California Irvine Brain...
BioCentury | Oct 12, 2018
Emerging Company Profile

Spinogenix’s Spine Craft

...Clinical status: Preclinical Founded: 2016 by Stella Sarraf University collaborators: University of California San Diego, University of California Irvine...
BioCentury | Oct 11, 2018
Translation in Brief

Public funding highlights: 3Q18

...for progressing to chronic pain Grants Sept. 6 NIH Bruce Tromberg, a professor at the University of California Irvine...
Items per page:
1 - 10 of 140